Phase 1 of the Human Cell Lineage Large-scale Scientific Research Facility has been successfully completed in Guangzhou, south China’s Guangdong Province. As the first national-level life science mega-facility in the Guangdong-Hong Kong-Macao Greater Bay Area, it will provide foundational research support for in-depth cell lineage analysis, disease mechanism exploration and innovative drug development, marking a key milestone for the region’s life science innovation landscape.
A core national scientific infrastructure under China’s strategic layout for basic life science research, the facility focuses on cutting-edge fields including high-precision cell lineage mapping, systematic disease mechanism studies and novel pharmaceutical R&D. Upon full completion, it will serve as a critical innovation hub driving the GBA’s biopharmaceutical industrial upgrading, underpinning core technology breakthroughs and high-quality growth of China’s life health sector.
The main structure of the construction and installation project was officially topped out on December 28, 2025. All supporting works including facade curtain walls, internal ventilation systems and fire safety facilities have now been fully finished. Phase 2 fitting-out construction will kick off immediately after the phase 1 handover, with the entire project scheduled for full operational completion in 2028.

